8-K: Movano Health Faces Nasdaq Delisting Threat Over Delayed Quarterly Report

Movano Inc. (Movano Health) has received a notice from Nasdaq indicating non-compliance due to the delayed filing of its Form 10-Q for the quarter ended March 31, 2025, potentially leading to delisting.

Summary

• Movano Inc. (Movano Health) received a notice from the Nasdaq Stock Market on May 20, 2025, regarding non-compliance with Nasdaq Listing Rule 5250(c)(1).
• The non-compliance stems from the company's failure to timely file its Form 10-Q for the quarterly period ended March 31, 2025, which was due on May 15, 2025.
• Nasdaq has given Movano 60 calendar days, until July 21, 2025, to submit a plan to regain compliance.
• If Nasdaq accepts the compliance plan, the company may be granted up to 180 calendar days from the original due date (until November 11, 2025) to file the delinquent Form 10-Q and regain compliance.
• Should Nasdaq not accept the plan, Movano will have the option to appeal the decision to a Nasdaq Hearings Panel.
• The company issued a press release on May 23, 2025, announcing the receipt of this notice.

Sentiment

Score: 2

Explanation: The document reports a significant negative event: a notice of non-compliance from Nasdaq due to a delayed financial filing, leading to a potential delisting. This indicates operational and compliance issues, posing a direct threat to the company's public trading status.

Negatives

• Movano Inc. is not in compliance with Nasdaq listing rules due to a delayed financial filing.
• The company faces a potential delisting from the Nasdaq Stock Market if it fails to regain compliance.
• The Form 10-Q for the quarter ended March 31, 2025, was due on May 15, 2025, but has not yet been filed.

Risks

• The timing of Movano's submission of a compliance plan to Nasdaq.
• Nasdaq's acceptance or rejection of the submitted compliance plan.
• The duration of any extension that may be granted by Nasdaq for filing the delinquent report.
• The potential inability of Movano to meet Nasdaq's requirements for continued listing.
• Uncertainties associated with the company's preparation of the delinquent Form 10-Q.
• The possibility of additional delays in the filing of the delinquent Form 10-Q and other future SEC filings.

Future Outlook

Movano Inc. intends to submit a plan to Nasdaq to regain compliance with the listing rules. The company is working towards filing its delinquent Form 10-Q and aims to meet Nasdaq's requirements to avoid delisting.

Management Comments

• The report was signed by J Cogan, Chief Financial Officer of Movano Inc.

Industry Context

This announcement highlights a common challenge faced by smaller public companies in maintaining timely financial reporting compliance, which is critical for investor confidence and market integrity. While not directly related to broader industry trends in health wearables, it underscores the importance of robust internal controls and financial operations for all publicly traded entities.

Stakeholder Impact

• Shareholders: Face increased risk of stock delisting, which could severely impact liquidity and valuation.
• Investors: May lose confidence due to compliance issues and delayed financial transparency.
• Regulatory Authorities: Will closely monitor the company's efforts to regain compliance.

Next Steps

• Movano Inc. must submit a plan to Nasdaq to regain compliance by July 21, 2025.
• The company needs to file its Form 10-Q for the quarter ended March 31, 2025, potentially by November 11, 2025, if an extension is granted.
• If Nasdaq does not accept the compliance plan, Movano has the option to appeal to a Nasdaq Hearings Panel.

Key Dates

Recommendation

Keywords

Movano Health, Nasdaq, Delisting, Form 10-Q, SEC filing, Compliance, Financial reporting, MOVE stock, Listing Rule 5250(c)(1), Quarterly report